Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hamrell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Public Health Policy|January 1, 1987
The Heart Healthy Vermonter ProgramE B Thompson, M Hamrell, R R Coffin
Advances in Enzyme Regulation|January 1, 1978
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killingW D Sedwick, M J Fyfe, M Hamrell, et al.
Molecular Pharmacology|November 1, 1981
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell lineM Hamrell, J Laszlo, O E Brown, et al.
Molecular Pharmacology|November 1, 1982
Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell linesW D Sedwick, M Hamrell, O E Brown, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1989
Report of the New England Task Force on Reducing Heart Disease and Stroke RiskS Havas, S Wozenski, R Deprez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Public Health Policy|January 1, 1987
The Heart Healthy Vermonter ProgramE B Thompson, M Hamrell, R R Coffin
Advances in Enzyme Regulation|January 1, 1978
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killingW D Sedwick, M J Fyfe, M Hamrell, et al.
Molecular Pharmacology|November 1, 1981
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell lineM Hamrell, J Laszlo, O E Brown, et al.
Molecular Pharmacology|November 1, 1982
Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell linesW D Sedwick, M Hamrell, O E Brown, et al.
Public Health Reports (Washington, D.C. : 1974)|March 1, 1989
Report of the New England Task Force on Reducing Heart Disease and Stroke RiskS Havas, S Wozenski, R Deprez, et al.
Pageof 1